ProfileGDS4459 / ENSG00000101161
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 73% 70% 73% 71% 71% 63% 71% 69% 68% 69% 65% 72% 67% 60% 69% 57% 59% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.4273
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.2170
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.5973
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.371
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.3671
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.9163
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.571
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.369
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2968
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.3569
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.9165
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.5972
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.1567
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.7560
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.3669
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.6457
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.759